Low-Dose High-Frequency Enzyme Replacement Therapy Prevents Fractures without Complete Suppression of Painful Bone Crises in Patients with Severe Juvenile Onset Type I Gaucher Disease
- 1 September 1998
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 24 (3) , 296-302
- https://doi.org/10.1006/bcmd.1998.0195
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Clinical Course of Treated and Untreated Gaucher Disease. A Study of 45 PatientsBlood Cells, Molecules, and Diseases, 1995
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Gaucher disease: new molecular approaches to diagnosis and treatmentScience, 1992
- Enzyme Augmentation in Moderate to Life-Threatening Gaucher DiseasePediatric Research, 1992
- Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher diseaseThe Journal of Pediatrics, 1992
- Gaucher's DiseaseNew England Journal of Medicine, 1991
- Hemorrhage associated with ?bone crisis? in Gaucher's disease identified by magnetic resonance imagingSkeletal Radiology, 1991
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- OSTEOARTICULAR MANIFESTATIONS OF GAUCHERʼS DISEASEThe Lancet Healthy Longevity, 1967
- Skeletal Manifestations and Treatment of Gaucherʼs DiseaseJournal of Bone and Joint Surgery, 1966